Press release
November 12, 2026
Moleculin Secures Australian Patent for Annamycin Formulation Technology
Moleculin Biotech, Inc. (MBRX)
5300 Memorial Drive, Suite 950
Houston, TX, 77007
info@moleculin.com
(713) 300-5160
Sign Up For Alerts
Contact Us:
info@moleculin.com
Copyright © 2026 Moleculin. All Rights Reserved
Privacy Policy Disclaimer
5300 Memorial Drive, Suite 950 |Houston, TX, 77007
info@moleculin.com
(713) 300-5160
Sign Up For Alerts
Contact Us:
info@moleculin.com
Copyright © 2026 Moleculin, Inc. All Rights Reserved
Privacy Policy Disclaimer